Q&A on the Malaria Vaccine Implementation Programme (MVIP)
This web page provides answers to frequently asked questions about the RTS,S/AS01 (RTS,S) malaria vaccine and the malaria vaccine implementation program, which will assess the operational feasibility of administering the RTS,S vaccine in a real-life setting. RTS,S was developed through a partnership between GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative, with support from the Bill & Melinda Gates Foundation and a network of African research centers.
Author: World Health Organization
» Visit web page (English)
(Located at www.who.int)
Resource types: Website